知镜 Cognispect · 医学文献与研究工作台

The role and clinical significance of the miR‑378a‑3p/MAPK1 axis in hypertensive vascular remodeling.

Wang S, Hu S, Liu L, Li L.
American journal of hypertension · 2026-11-01 · PMID 42535900

文献摘要

Background Primary hypertension is a prevalent cardiovascular disease contributing to a heavy global health burden. To investigate serum miR‑378a‑3p expression in hypertensive patients and its mechanism in OX‑LDL‑mediated vascular smooth muscle cell (VSMC) dysfunction. Methods Two hundred eighty-six primary hypertension patients and 132 healthy controls were enrolled, and serum miR‑378a‑3p levels and clinical parameters were detected. ROC curve and multivariate logistic regression were applied for diagnostic and risk factor analyses. In vitro cultured human aortic VSMCs were used to assess cell function, and phenotypic transformation via qRT‑PCR, CCK‑8, Transwell, and Western blot. Target gene binding was verified by bioinformatics and dual‑luciferase assay. Results miR‑378a‑3p was significantly downregulated in hypertensive patients and identified as an independent protective factor, whereas LDL‑C, PRA, Ang II, and ALD were independent risk factors. OX‑LDL downregulated miR‑378a‑3p and promoted VSMC dysfunction, while miR‑378a‑3p overexpression alleviated these injuries by directly targeting MAPK1. Conclusions miR-378a-3p shows potential as an auxiliary screening biomarker for hypertension risk stratification and may serve as a promising therapeutic target by regulating VSMC function via MAPK1.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。